Background and Aim: Gastric intestinal metaplasia represents a risk factor for intestinal type of gastric cancer. Gastric intestinal metaplasia seems to be associated with Helicobacter pilory infection in relatives of patients with gastric cancer. The aim of this study was to determine the prevalence, clinical, endoscopic and histological features of gastric intestinal metaplasia. Material and Methods: We retrospectively analyzed the esophagogastroduodenoscopies with biopsies performed between January 1, 2014 and October 31, 2014. Collected and analyzed data included age, gender, symptoms, endoscopic and histological findings. Results: Four hundred eighty-two patients were included in the study. One hundred thirty-seven patients had gastric intestinal metaplasia, which presented a prevalence was 28,4%. A similar distribution between gender was observed with a significant increase of gastric intestinal metaplasia with age (p=0,0001). Regarding the indication for endoscopy, the prevalence of gastric intestinal metaplasia was: 17 % among patients with dyspeptic syndrome, 2 % in patients with anemia and 5 % in patients examined for other symptoms. Endoscopic findings showed gastric intestinal metaplasia was significantly associated with atrophic gastritis (p=0.0001), erythematous gastritis (p=0.0079), while there was no association with erosive gastritis (p=0.24) and peptic ulcer (p=0.19). Conclusions: Gastric intestinal metaplasia is frequently recorded in patients undergoing in esophagogastroduodenoscopies with associated biopsies. Endoscopic findings like erythema and atrophy is strongly associated with gastric intestinal metaplasia emphasizing the importance of sampling biopsies. 
Introduction
Gastric cancer is the second most frequent cause of cancerrelated mortality worldwide [1] . More than 95% of the total number of malignancies are adenocarcinoma [2] . According to Lauren classification [3] gastric cancer is divided into 2 major histologic types: intestinal and diffuse. Evidence shows that the pathogenesis of gastric cancer, particularly the intestinal-type, involves a series of sequential phases from gastritis associated with persistent Helicobacter pylori infection which may progress towards chronic atrophic gastritis, intestinal metaplasia and dysplasia to invasive carcinoma [4, 5] . Thus gastric intestinal metaplasia is considered a precancerous lesion, increasing the risk of developing gastric cancer by 6-fold. Intestinal metaplasia seems to be more frequently encountered in relatives of patients with gastric patients, in elderly patients and in case of infections with Helicobacter pilory. [6] . According to recent studies, annual endoscopic follow-up performed in patients with gastro-intestinal metaplasia coul detect gastric cancer in an early stage, leading to a significant improvement of the clinical evolution and increase in survival rates. [7] .
The aim of this study was to determine the prevalence, clinical, endoscopic and histological features of gastric intestinal metaplasia.
Materials and methods
This was a retrospective review of the esophagogastroduodenoscopies with biopsies performed between January 1, 2014 and October 31, 2014 in the Endoscopic Unit at Mures County Hospital. Data including age, gender, symptoms, endoscopic and histological findings were collected for the study.
Endoscopic and histological evaluation
All the endoscopic examinations were performed by trained endoscopists, using an Olympus Exera video-endoscope. An informed consent to undergo endoscopy was obtained from all the patients and the study was approved by the ethics and scientific review committee of the institution. Biopsy specimens were fixed in formalin solution and embedded in paraffin. For the histopatological evaluation, the Giemsa, Hematoxylin-Eosin, PAS-Alcian Blue stains were performed. Helicobacter pylori infection was determined only by histological examination of biopsies.
Statistical Methods:
Data were tabled and analyzed using Microsoft Excel software (Microsoft Corporation, WA, USA). All statistical analyses were performed using GraphPad Software, CA, USA. Data were compared by using the chi-square test, and P value of < 0,05 was considered statistical significant. Fisher's exact test was used when the values in the contingency tables were lower than 5.
Results
A total of 482 patients (283 females and 199 males) underwent esophagogastroduodenoscopy during the aforementioned time period. Patient demographics are presented in Table I . The main indication for endoscopy was dyspeptic syndrome (267 cases), anemia (58 cases) and 85 patients were examined for other symptoms. Indications for upper endoscopy are presented in Table II . Pathological endoscopic results were: 154 cases of erythematous gastritis, 90 cases of erosive gastritis, 62 cases of atrophic gastritis and 52 cases of peptic ulcer. Endoscopic findings are presented in Table III . The presence of Helicobacter pylori infection was assessed by histological examination of biopsies. Out of the 482 patients enrolled in this study , 139 (28.8% ) had histologic evidence of Helicobacter pylori infection.
We found a significant correlation of Helicobacter pylori infection with both, endoscopic (p=0,0008) and histologic (p=0,0181) evidence of atrophic gastritis (Table IV) .
Out of the 482 patients endoscopically examined, 137 had gastric intestinal metaplasia at histological examination , with a prevalence of 28.4%. A similar distribution between gender was observed with a significant increase of gastric intestinal metaplasia with age (chi-square for linear trend 23.09, p= 0.0001). (Table V) . Regarding the indication for upper endoscopy, the prevalence of gastric intestinal metaplasia was: 17 % among patients with dyspeptic syndrome, 2 % in patients with anemia and 5 % in patients examined for other symptoms. No significant statistical association was noticed (p=0.32).
Gastric interstinal metaplasia was found at endoscopy in 69% of patients with atrophic gastritis (43 of 62), compared to 36% in patients with gastric ulcers (19 of 52) and 23% in those with erythematous gastritis (31 of 154).
We found a positive correlation between gastric ulcer at endoscopic examination and the histological evidence of gastric atrophy (p=0,0418). Also gastric intestinal metaplasia was significantly associated with atrophic gastritis (p= 0,0001), and erythematous gastritis (p= 0,0079), while there was no association with erosive gastritis (p= 0,24) and peptic ulcer (p=0,19) (Table VI) .
Disscussions
The primary aim of this study was to determine the prevalence of gastric intestinal metaplasia in patients investigated by esophagogastroduodenoscopy for different symptoms and its clinical and endoscopical characteris- tics. Many studies published in the last years reported data regarding the prevalence of gastric intestinal metaplasia and its relationship with age and Helicobacter pylori infection. According to a recent metaanalysis, the prevalence rates of gastric intestinal metaplasia are in a wide range from 7.1% to 42.5%, depending on diagnostic methods and countries [8] . In a study performed in the Netherlands, Craanen et al. detected gastric intestinal metaplasia in 25.3% of the 533 patients examined by upper endoscopy. The prevalence of gastric intestinal metaplasia was significantly higher in patients over 50 years (31.9%) compared with those < 50 years (10.4%). Also they reported the highest prevalence of gastric intestinal metaplasia in the age group over 80 years [9] . Similar data were observed in Korea, where gastric intestinal metaplasia was observed in 12.5% of 4023 patients who underwent screening endoscopy. The prevalence of gastric intestinal metaplasia significantly increased with age from 3.4 % in patients under 40 years to 17.4% in those ≥ 60 years, with a predominance for males [10] . In a study from Italy published in 2005, Zullo et al found gastric intestinal metaplasia in 32.3% of 179 patients with Helicobacter pylori infection and peptic ulcer with a mean-age 69.5 years [11] . Similar to this reported data, in our study the prevalence of gastric intestinal metaplasia was 28.4% and increased significantly with age from 13.6% in patients <50 years to 34.9% in those >50 years. The association between gastric metaplasia and advanced age suggest a potential role of a chronic injury of the gastric mucosa in triggering the disease [12] . Although it is generally understood that the prevalence of gastric intestinal metaplasia and the risk of its progression is higher in males [13, 14] , we found a similar distribution between gender in accordance with previous reported data [15, 16] . As previously mentioned, Helicobacter pylori infection is considered to be an important initial step in gastric carcinogenesis, increasing the risk of developing gastric cancer at least six folds [17] . There are abundant data in the literature [18, 19] revealing an association of premalignant gastric lesions/conditions and Helicobacter pylori infection. In our study, we evaluated Helicobacter pylori infection only by histological examination of gastric biopsy specimens and the prevalence was 28.8%. Our findings showed a significant correlation between Helicobacter pylori infection and histologic evidence of atrophic gastritis (p=0,0181), this association being even stronger between infection and atrophic gastritis at endoscopic examination (p=0,0008). This data emphasizes the role of Helicobacter pylori infection as initiator or promoter of gastric carcinogenesis. We did not find the same association between Helicobacter pylori infection and gastric intestinal metaplasia (p=1.000). The main explanation is that at the final stage of the disease, gastric atrophy with intestinal metaplasia were very serious and determine an unfavorable environment for Helicobacter pylori, leading to reduction or disappearance of the organism [20] . Regarding the endoscopic findings, we found a positive correlation between erythematous gastritis and the histological evidence of gastric intestinal metaplasia (p=0.066), and also an even stronger association between atrophic gastritis and gastric intestinal metaplasia (p=0.0001). These associations were previously described by some authors [21] [22] [23] , they emphasized that the malignant transformation of gastric mucosa involves a temporary sequence starting with the acquisition of Helicobacter pylori infection.
Conclusions
Gastric intestinal metaplasia is frequently recorded in patients undergoing upper gastrointestinal endoscopy with biopsy sampling. The prevalence of gastric intestinal metaplasia varies widely between countries. In our study the overall prevalence of intestinal metaplasia was 28.4%, considered to be a mean value compared to other data reported in the literature. We did not observe a predisposition of gastric atrophy or intestinal metaplasia for any gender. The presence of Helicobacter pylori is associated with increased risk of atrophic gastritis. Endoscopic findings like erythema and atrophy are strongly associated with gastric intestinal metaplasia emphasizing the importance of sampling biopsies.
